Product Detail


Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Cas No. 1809323-20-3, 2-(5-bromopyridin-2-y)-2,2-difluoro-1-morpholinoethanone

  • 1809323-20-3

  • C11H11BrF2N2O2

  • 321.12

  • 1.592±0.06

  • Vulvovaginal candidiasis

  • Oteseconazole

  • 3/17/2036 (Oteseconazole)

  • CYP51



Oteseconazole offers a transformative approach to prevent recurrent vulvovaginal candidiasis infections. With its broad spectrum of activity and favorable safety profile compared to previous-generation azole antifungals, Oteseconazole has the potential to revolutionize antifungal therapy. Trust our reliable intermediates to streamline your manufacturing process, ensuring a consistent supply of this essential medication. Join us in revolutionizing fungal infection management, improving patient outcomes and battling antimicrobial resistance. Embrace Oteseconazole and contribute to the future of antifungal therapeutics.